These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17960950)

  • 21. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies.
    Barbieri M; Hawkins N; Sculpher M
    Value Health; 2009; 12(2):193-201. PubMed ID: 18700865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Navigating time and uncertainty in health technology appraisal: would a map help?
    McCabe C; Edlin R; Hall P
    Pharmacoeconomics; 2013 Sep; 31(9):731-7. PubMed ID: 23877738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why it's Time to Abandon the ICER.
    Paulden M
    Pharmacoeconomics; 2020 Aug; 38(8):781-784. PubMed ID: 32390066
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bayesian approach for the cost-effectiveness evaluation of healthcare technologies].
    Berchialla P; Gregori D; Brunello F; Veltri A; Petrinco M; Pagano E
    Epidemiol Prev; 2009; 33(3):123-8. PubMed ID: 19776461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makers.
    de Groot S; Rijnsburger AJ; Versteegh MM; Heymans JM; Kleijnen S; Redekop WK; Verstijnen IM
    BMJ Open; 2015 Jul; 5(7):e007241. PubMed ID: 26220869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Price of Substitute Technologies.
    Santos AS; Guerra-Junior AA; Noronha KVMS; Andrade MV; Ruas CM
    Value Health Reg Issues; 2019 Dec; 20():154-158. PubMed ID: 31561148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel research design can aid disinvestment from existing health technologies with uncertain effectiveness, cost-effectiveness, and/or safety.
    Haines T; O'Brien L; McDermott F; Markham D; Mitchell D; Watterson D; Skinner E
    J Clin Epidemiol; 2014 Feb; 67(2):144-51. PubMed ID: 24275500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Health technology assessment: II. Cost effectiveness analysis].
    Secoli SR; Nita ME; Ono-Nita SK; Nobre M
    Arq Gastroenterol; 2010; 47(4):329-33. PubMed ID: 21225140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for budget impact analysis of health technologies in Brazil].
    Ferreira-Da-Silva AL; Ribeiro RA; Santos VC; Elias FT; d'Oliveira AL; Polanczyk CA
    Cad Saude Publica; 2012 Jul; 28(7):1223-38. PubMed ID: 22729254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.
    Crispi F; Naci H; Barkauskaite E; Osipenko L; Mossialos E
    Appl Health Econ Health Policy; 2019 Apr; 17(2):189-211. PubMed ID: 30367349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?
    Edlin R; Hall P; Wallner K; McCabe C
    Value Health; 2014 Jun; 17(4):438-44. PubMed ID: 24969005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to evaluate whether a new technology in the operating room is cost-effective from society's viewpoint.
    Tan JM; Macario A
    Anesthesiol Clin; 2008 Dec; 26(4):745-64, viii. PubMed ID: 19041627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
    Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System.
    Jansen JP; Incerti D; Curtis JR
    J Manag Care Spec Pharm; 2019 May; 25(5):518-521. PubMed ID: 31039069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space.
    McCaffrey N; Agar M; Harlum J; Karnon J; Currow D; Eckermann S
    PLoS One; 2015; 10(3):e0115544. PubMed ID: 25751629
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.